Through community engagement, the root causes of healthcare disparities can be addressed, and the health and resiliency of individuals can be dramatically improved. The post Increasing Health Equity Through Accessibility and Education appeared first on MedCity News.
Inspired by the speed and ease of at-home Covid-19 tests, OncoSwab is developing a test for lung cancer that detects signs of the disease from a nasal swab. The test could become an alternative to the medical imaging currently used to screen for lung cancer. The post Startup OncoSwab Aims to Make Lung Cancer Detection…
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care. The post Evernorth Invests $100M for AI Specialty Pharmacy Program appeared first on MedCity News.
Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. The post At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were…
A just-released report from SullivanCotter sees salaries and incentive pay creeping up
By MATTHEW HOLT I know my many fans love me delving into the world of why we get seemingly incorrect trivial bills in health care, and what they all mean. The long telenovella of the $39.94 bill from Labcorp is as yet stalled with One Medical apparently resubmitting the original claim with the new preventative…
This brief provides an overview of premiums and benefits in Medicare Advantage plans that are available for 2026 and key trends over time.
More effective and proactive care requires a framework that will enable the U.S. healthcare system to better meet the inevitable challenges of an aging population and pave the way for a sustainable and equitable future. Monitoring and other digital health enabled tools are helping to build that framework by offering a new medium for care…
Zepbound’s clinical tests in obstructive sleep apnea showed improvement in breathing disruptions that were accompanied by reductions in body weight. The new approval gives the Eli Lilly medicine the opportunity to become a blockbuster seller in yet another indication. The post Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea appeared first on…
By investing upfront in a more highly trained homecare workforce, states can avoid the massive costs associated with acute interventions and admissions to hospitals and residential facilities. The post States are Advancing Homecare’s Next Big Step — Paying Caregivers for Skill, Not Just Time appeared first on MedCity News.